-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SovYCx0VS/iD32BDLZDarLgOdnOjaYT7PDXnJGGHmevdkZOGjJVr59DecX12QR/I TwOS2mkDuv3DWNdxAgnntA== 0000950134-06-011518.txt : 20060613 0000950134-06-011518.hdr.sgml : 20060613 20060613164406 ACCESSION NUMBER: 0000950134-06-011518 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060607 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060613 DATE AS OF CHANGE: 20060613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 06902690 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 8-K 1 f21309e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 7, 2006
SOLEXA, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
     
000-22570
(Commission File No.)
  94-3161073
(IRS Employer Identification No.)
25861 Industrial Blvd.
Hayward, California 94545

(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (510) 670-9300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 1.01 Entry into a Material Definitive Agreement.
Item 9.01. Financial Statements and Exhibits.
SIGNATURE
EXHIBITS
EXHIBIT 10.39


Table of Contents

Item 1.01 Entry into a Material Definitive Agreement.
On June 7, 2006, the Compensation Committee of the Board of Directors of Solexa, Inc. (“Solexa”) (the “Compensation Committee”) amended Solexa’s 2005-2006 Bonus Plan (the “Plan”) to provide, among other things, that the degree to which target bonuses are earned by eligible employees under the Plan will be determined based on the timing and amount of sales of Solexa’s Sequencing-by-Synthesis instrumentation systems and related services as well as the achievement of year-end cash balance targets, in both cases as determined by either the Board of Directors or Compensation Committee.
All employees of Solexa who perform at least 30 hours of service per week and all regular full-time employees of Solexa Limited, a subsidiary of Solexa, who are employed as of September 30, 2006 and through the applicable bonus payment date are eligible to participate in the Plan, as amended. The payment of bonuses to director-level employees and above will no longer be contingent upon the achievement of specified cash flow targets. In addition, bonuses for director-level employees and above will be payable in the form of cash and fully-vested common stock under Solexa’s 2005 Equity Incentive Plan. Bonuses for all other employees will be payable in the form of cash except to the extent aggregate bonus payouts exceed certain targets.
A copy of the Plan, as amended, is attached as Exhibit 10.39 hereto and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c)      Exhibits:
     
Exhibit    
Number   Description
 
   
10.39
  2005-2006 Bonus Plan, as amended.

 


Table of Contents

SIGNATURE
          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  SOLEXA, INC.
 
 
Dated: June 13, 2006  By:   /s/ Kathy A. San Roman    
    Name:   Kathy A. San Roman   
    Title:   Vice President, Human Resources and
Administration 
 
 

 


Table of Contents

EXHIBITS
     
Exhibit    
Number   Description
 
   
10.39
  2005-2006 Bonus Plan, as amended.

 

EX-10.39 2 f21309exv10w39.htm EXHIBIT 10.39 exv10w39
 

Exhibit 10.39
SUMMARY OF TERMS OF
SOLEXA, INC.
2005-2006 BONUS PLAN, AS AMENDED
I.       OBJECTIVES
  A.   Focus the employees of Solexa, Inc., a Delaware corporation (“Solexa”) on a shared set of goals.
 
  B.   Retain key staff and improve competitiveness in recruitment.
II.      ELIGIBILITY
  A.   All employees of Solexa who perform at least 30 hours of service per week and all regular full-time employees of Solexa Limited, a subsidiary of Solexa registered in England and Wales, who are employed as of September 30, 2006 and through the applicable bonus payment date are eligible to participate in the 2005-2006 Bonus Plan, as amended (the “Plan”).
III.       CALCULATION OF TARGET BONUSES
  A.   Eligible employees will be entitled to a target bonus based on the sum of such employee’s salary earned during a period of time to be set by either the Board of Directors of Solexa (the “Board") or the Compensation Committee of the Board (the “Compensation Committee") multiplied by the target percentage for each employee, also as determined by the Board or Compensation Committee.
 
  B.   The degree to which target bonuses are earned will be determined based on the achievement of objectives relating to (i) the timing and amount of sales of Solexa’s Sequencing-by-Synthesis instrumentation systems and related services and (ii) year-end cash balance targets, in both cases as determined by either the Board or Compensation Committee.
IV.       OTHER PROVISIONS
  A.   The payment of bonuses to director-level employees and above will be in the form of cash and fully-vested common stock under Solexa’s 2005 Equity Incentive Plan. Bonuses for all other employees will be payable in the form of cash except to the extent aggregate bonus payouts exceed certain targets, in which case the excess bonus payouts will be made in fully-vested common stock under Solexa’s 2005 Equity Incentive Plan.
 
  B.   The Board or Compensation Committee shall have the discretion to adjust the targets and bonus payments light of changing circumstances and to amend or cancel the Plan at any time.

 

-----END PRIVACY-ENHANCED MESSAGE-----